These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1183095)

  • 21. [Differential diagnosis of hypertension using the angiotensin II antagonist saralasin].
    Knauf H; Burmeister P; Büttner C; Hoppe-Seyler G; Schollmeyer P
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():214-5. PubMed ID: 613578
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of saralasin in preventing renal failure in ischemic transplanted kidneys.
    Munda R; Alexander JW
    Am Surg; 1980 Nov; 46(11):637-9. PubMed ID: 7001966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation between the hypotensive and renin-stimulating effect of diuretic therapy in hypertensive patients].
    Bianchini C; Sala C; Terzoli L; Sernesi L; Leonetti G; Zanchetti A
    Boll Soc Ital Cardiol; 1978; 23(10):1739-47. PubMed ID: 400389
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic prospects in the use of saralasin].
    Pigliucci GM; Valenza M; Rosati F; Cagossi M
    Chir Patol Sper; 1979 Oct; 27(5):491-7. PubMed ID: 261945
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
    Atkinson J; Lüthi P; Péra-Bally R; Peters-Haefeli L
    J Pharmacol Exp Ther; 1982 May; 221(2):453-60. PubMed ID: 6281416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The antihypertensive effect of saralasin in rabbits with neurogenic interoreceptive hypertension].
    Hartrodt W; Orlow G; Brosowski KH; Gürke R
    Biomed Biochim Acta; 1985; 44(3):455-64. PubMed ID: 3890848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
    Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I
    JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotension during angiotensin blockade with saralasin.
    Beckerhoff R; Furrer J; Vetter W; Nussberger J; Siegenthaler W
    Br Med J; 1976 Oct; 2(6040):849. PubMed ID: 990716
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertension and the renin-angiotensin system in the congenital hydronephrosis rat with non-obstructive pelviureteric junction abnormalities.
    Tauchi K; Kanehara H
    Exp Nephrol; 1996; 4(1):60-4. PubMed ID: 8788602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: New prospects in renal hypertension.
    Br Med J; 1975 Jul; 3(5975):59-60. PubMed ID: 1139228
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of saralasin and serum in myohaemoglobinuric acute renal failure of rats.
    Bauereiss K; Hofbauer KG; Konrads A; Gross F
    Clin Sci Mol Med; 1978 May; 54(5):555-60. PubMed ID: 750157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of the hypertensive crisis by blocking the renin-angiotensin system (author's transl)].
    Wambach G; Kaufmann W
    MMW Munch Med Wochenschr; 1982 Jul; 124(27):638-40. PubMed ID: 6810156
    [No Abstract]   [Full Text] [Related]  

  • 35. Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function.
    Yarger WE; Schocken DD; Harris RH
    J Clin Invest; 1980 Feb; 65(2):400-12. PubMed ID: 7356687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
    Douglas JR; Johnson EM; Heist JF; Marshall GR; Needleman P
    J Pharmacol Exp Ther; 1976 Jan; 196(1):35-43. PubMed ID: 1246014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic relevancy of saralasin in renin-dependent hypertension].
    Röckel A; Wernze H; Spech HJ; Scheitza E; Hennemann H; Heidland A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1307-10. PubMed ID: 1029985
    [No Abstract]   [Full Text] [Related]  

  • 39. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin blockade in hypertension.
    Streeten DH; Anderson GH
    Ann Intern Med; 1977 Mar; 86(3):353-4. PubMed ID: 842997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.